RIME
Algorhythm Holdings, Inc. (RIME) Risks & Opportunities Analysis (2026)
No material changes this month.
Risks
Negative interest coverage and sub-1.0 liquidity ratios leave RIME more exposed to refinancing or working-capital stress than better-capitalized peers if demand softens.
A high debt-to-equity ratio versus peers increases sensitivity to rate and credit conditions, limiting flexibility relative to less levered competitors in the same market.
Days sales outstanding near 62 days suggests slower cash collection than stronger peers, which can pressure liquidity and constrain growth investment if customers delay payments.
A negative cash conversion cycle helps working capital, but RIME’s advantage is partly offset by weak coverage metrics, so peers with stronger balance sheets remain better positioned.
Opportunities
Negative net debt to EBITDA indicates net cash positioning, giving RIME more balance-sheet resilience than leveraged peers if industry demand becomes volatile.
A negative cash conversion cycle supports faster internal funding than peers with longer inventory or receivables cycles, improving flexibility in a tighter credit environment.
Low inventory intensity reduces working-capital drag versus peers carrying more stock, which can support responsiveness if customer demand improves.
If operating performance stabilizes, RIME’s net-cash profile could translate into relatively faster deleveraging capacity than peers burdened by higher absolute debt loads.
Overall Score
RIME’s net-cash and working-capital efficiency provide some peer-relative resilience, but weak interest coverage, subpar liquidity, and higher leverage keep forward positioning only moderately favorable.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Algorhythm Holdings, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.
